London equities moved higher on Tuesday, with the FTSE 100 rising 0.34% to 10,721.48 by 0925 GMT as gains in pharmaceutical stocks offset pressure from higher oil prices and elevated borrowing costs. The move reflected a mixed market environment in which company-specific developments supported selected sectors even as investors continued to assess geopolitical risks and the implications for UK interest rates and economic growth.

AstraZeneca Deal Lifts Pharmaceutical Stocks

The healthcare sector was among the strongest performers, with the UK pharmaceutical sector advancing 1.5%. AstraZeneca rose 1.7% to a two-month high after announcing plans to invest $2 billion in Summit Therapeutics and collaborate on a series of studies evaluating their cancer treatments in combination.

The transaction highlights the continued importance of oncology research and strategic partnerships within the global pharmaceutical industry. For AstraZeneca, the agreement expands its exposure to cancer-treatment development while providing another avenue for potential pipeline expansion. Peer GSK also gained 1.7%, contributing to the broader strength in healthcare stocks.

Mining Stocks Recover as Copper Prices Rebound

Industrial metals stocks also contributed to the FTSE 100 advance. The sector rose 1.3% after falling more than 1% in the previous session, tracking a recovery in copper prices.

Mining companies Glencore and Anglo American gained 1.6% and 1.7%, respectively. The rebound illustrates the sensitivity of UK equities to movements in global commodity markets, given the significant representation of mining and natural-resource companies within the London market.

At the same time, higher oil prices continued to influence global financial conditions. Rising energy costs have contributed to a repricing of interest-rate expectations and helped keep global bond yields at elevated levels. The UK benchmark 10-year gilt yield nevertheless eased on Tuesday after reaching its highest level since 2007 during the previous session.

Company-Specific Moves Add to a Mixed Market

Individual corporate developments produced additional volatility across London-listed shares. Vesuvius surged 21.7% after Austria-based RHI Magnesita proposed acquiring the metal-flow engineering company in a cash-and-stock transaction valued at approximately £1.37 billion.

Close Brothers climbed 11.2% after reporting annual adjusted operating profit of £120.3 million, exceeding the company-compiled consensus of £111 million. By contrast, British American Tobacco declined 1.7% after warning that annual growth is likely to come in toward the lower end of its forecast range.

Investors in Israel and global markets are now looking toward the UK’s upcoming economic data for further direction. Second-quarter GDP figures will provide additional insight into the strength of the British economy at a time when higher energy costs and elevated borrowing expenses are complicating the outlook. The interaction between corporate earnings, commodity prices, bond yields and economic growth will remain central to the FTSE 100’s performance as markets assess the balance between sector-specific strength and broader macroeconomic pressure.